227 related articles for article (PubMed ID: 17486073)
1. Pharmacological inhibition of protein kinase CK2 reverts the multidrug resistance phenotype of a CEM cell line characterized by high CK2 level.
Di Maira G; Brustolon F; Bertacchini J; Tosoni K; Marmiroli S; Pinna LA; Ruzzene M
Oncogene; 2007 Oct; 26(48):6915-26. PubMed ID: 17486073
[TBL] [Abstract][Full Text] [Related]
2. Intracellular hydrogen peroxide production is an upstream event in apoptosis induced by down-regulation of casein kinase 2 in prostate cancer cells.
Ahmad KA; Wang G; Ahmed K
Mol Cancer Res; 2006 May; 4(5):331-8. PubMed ID: 16687488
[TBL] [Abstract][Full Text] [Related]
3. RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines.
Yang C; Hornicek FJ; Wood KB; Schwab JH; Mankin H; Duan Z
Cancer Chemother Pharmacol; 2009 Aug; 64(3):607-14. PubMed ID: 19125251
[TBL] [Abstract][Full Text] [Related]
4. A role for protein kinase CK2 in cell proliferation: evidence using a kinase-inactive mutant of CK2 catalytic subunit alpha.
Lebrin F; Chambaz EM; Bianchini L
Oncogene; 2001 Apr; 20(16):2010-22. PubMed ID: 11360185
[TBL] [Abstract][Full Text] [Related]
5. Casein kinase II inhibition induces apoptosis in pancreatic cancer cells.
Hamacher R; Saur D; Fritsch R; Reichert M; Schmid RM; Schneider G
Oncol Rep; 2007 Sep; 18(3):695-701. PubMed ID: 17671722
[TBL] [Abstract][Full Text] [Related]
6. Casein kinase 2 regulates both apoptosis and the cell cycle following DNA damage induced by 6-thioguanine.
Yamane K; Kinsella TJ
Clin Cancer Res; 2005 Mar; 11(6):2355-63. PubMed ID: 15788687
[TBL] [Abstract][Full Text] [Related]
7. p53 is dispensable for the induction of apoptosis after inhibition of protein kinase CK2.
Schneider CC; Hessenauer A; Montenarh M; Götz C
Prostate; 2010 Feb; 70(2):126-34. PubMed ID: 19760628
[TBL] [Abstract][Full Text] [Related]
8. Validation of protein kinase CK2 as oncological target.
Seeber S; Issinger OG; Holm T; Kristensen LP; Guerra B
Apoptosis; 2005 Aug; 10(4):875-85. PubMed ID: 16133877
[TBL] [Abstract][Full Text] [Related]
9. Casein Kinase II: an attractive target for anti-cancer drug design.
Hanif IM; Hanif IM; Shazib MA; Ahmad KA; Pervaiz S
Int J Biochem Cell Biol; 2010 Oct; 42(10):1602-5. PubMed ID: 20558317
[TBL] [Abstract][Full Text] [Related]
10. A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax.
Li X; Hong L; Zhao Y; Jin H; Fan R; Du R; Xia L; Luo G; Fan D
Biochem Cell Biol; 2007 Dec; 85(6):741-50. PubMed ID: 18059532
[TBL] [Abstract][Full Text] [Related]
11. Programmed cell death protein 5 (PDCD5) is phosphorylated by CK2 in vitro and in 293T cells.
Salvi M; Xu D; Chen Y; Cabrelle A; Sarno S; Pinna LA
Biochem Biophys Res Commun; 2009 Sep; 387(3):606-10. PubMed ID: 19616514
[TBL] [Abstract][Full Text] [Related]
12. Reverse-phase protein microarrays (RPPA) as a diagnostic and therapeutic guide in multidrug resistant leukemia.
Maraldi T; Bertacchini J; Benincasa M; Guida M; De Pol A; Liotta LA; Petricoin E; Cocco L; Marmiroli S
Int J Oncol; 2011 Feb; 38(2):427-35. PubMed ID: 21132263
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase CK2alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia.
Kim JS; Eom JI; Cheong JW; Choi AJ; Lee JK; Yang WI; Min YH
Clin Cancer Res; 2007 Feb; 13(3):1019-28. PubMed ID: 17289898
[TBL] [Abstract][Full Text] [Related]
14. CK2 inhibits apoptosis and changes its cellular localization following ionizing radiation.
Yamane K; Kinsella TJ
Cancer Res; 2005 May; 65(10):4362-7. PubMed ID: 15899828
[TBL] [Abstract][Full Text] [Related]
15. Functional interaction of protein kinase CK2 and c-Myc in lymphomagenesis.
Channavajhala P; Seldin DC
Oncogene; 2002 Aug; 21(34):5280-8. PubMed ID: 12149649
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone-related protein (PTHrP) inhibits mitochondrial-dependent apoptosis through CK2.
Okoumassoun LE; Russo C; Denizeau F; Averill-Bates D; Henderson JE
J Cell Physiol; 2007 Sep; 212(3):591-9. PubMed ID: 17443683
[TBL] [Abstract][Full Text] [Related]
17. Order or chaos? An evaluation of the regulation of protein kinase CK2.
Olsten ME; Litchfield DW
Biochem Cell Biol; 2004 Dec; 82(6):681-93. PubMed ID: 15674436
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase CK2 as a druggable target.
Sarno S; Pinna LA
Mol Biosyst; 2008 Sep; 4(9):889-94. PubMed ID: 18704226
[TBL] [Abstract][Full Text] [Related]
19. In vivo reversal of P-glycoprotein-mediated multidrug resistance by efficient delivery of stealth RNAi.
Xiao H; Wu Z; Shen H; Luo AL; Yang YF; Li XB; Zhu DY
Basic Clin Pharmacol Toxicol; 2008 Oct; 103(4):342-8. PubMed ID: 18834355
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of CK2 expression and function in tumor cell lines displaying sensitivity vs. resistance to chemical induced apoptosis.
Di Maira G; Brustolon F; Tosoni K; Belli S; Krämer SD; Pinna LA; Ruzzene M
Mol Cell Biochem; 2008 Sep; 316(1-2):155-61. PubMed ID: 18560764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
